BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 11875080)

  • 1. Regulation of erythropoietin-induced STAT serine phosphorylation by distinct mitogen-activated protein kinases.
    Haq R; Halupa A; Beattie BK; Mason JM; Zanke BW; Barber DL
    J Biol Chem; 2002 May; 277(19):17359-66. PubMed ID: 11875080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythropoietin and Friend virus gp55 activate different JAK/STAT pathways through the erythropoietin receptor in erythroid cells.
    Yamamura Y; Senda H; Kageyama Y; Matsuzaki T; Noda M; Ikawa Y
    Mol Cell Biol; 1998 Mar; 18(3):1172-80. PubMed ID: 9488432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitogen-activated protein kinase plays an essential role in the erythropoietin-dependent proliferation of CTLL-2 cells.
    Sakamoto H; Kitamura T; Yoshimura A
    J Biol Chem; 2000 Nov; 275(46):35857-62. PubMed ID: 10960479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lnk inhibits erythropoiesis and Epo-dependent JAK2 activation and downstream signaling pathways.
    Tong W; Zhang J; Lodish HF
    Blood; 2005 Jun; 105(12):4604-12. PubMed ID: 15705783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythropoietin-induced serine 727 phosphorylation of STAT3 in erythroid cells is mediated by a MEK-, ERK-, and MSK1-dependent pathway.
    Wierenga AT; Vogelzang I; Eggen BJ; Vellenga E
    Exp Hematol; 2003 May; 31(5):398-405. PubMed ID: 12763138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-22 (IL-22) activates the JAK/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line. Pathways that are shared with and distinct from IL-10.
    Lejeune D; Dumoutier L; Constantinescu S; Kruijer W; Schuringa JJ; Renauld JC
    J Biol Chem; 2002 Sep; 277(37):33676-82. PubMed ID: 12087100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Src directly tyrosine-phosphorylates STAT5 on its activation site and is involved in erythropoietin-induced signaling pathway.
    Okutani Y; Kitanaka A; Tanaka T; Kamano H; Ohnishi H; Kubota Y; Ishida T; Takahara J
    Oncogene; 2001 Oct; 20(45):6643-50. PubMed ID: 11641791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. STAT1 is involved in signal transduction in the EPO induced HEL cells.
    Chu J; Gui CY; Fan J; Tang XD; Qiao RL
    Cell Res; 1998 Jun; 8(2):105-17. PubMed ID: 9669026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential constitutive activation between STAT-related proteins and MAP kinase in primary acute myelogenous leukaemia.
    Hayakawa F; Towatari M; Iida H; Wakao H; Kiyoi H; Naoe T; Saito H
    Br J Haematol; 1998 Jun; 101(3):521-8. PubMed ID: 9633897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The serine protease plasmin triggers expression of MCP-1 and CD40 in human primary monocytes via activation of p38 MAPK and janus kinase (JAK)/STAT signaling pathways.
    Burysek L; Syrovets T; Simmet T
    J Biol Chem; 2002 Sep; 277(36):33509-17. PubMed ID: 12093796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The functional synergy between IL-12 and IL-2 involves p38 mitogen-activated protein kinase and is associated with the augmentation of STAT serine phosphorylation.
    Gollob JA; Schnipper CP; Murphy EA; Ritz J; Frank DA
    J Immunol; 1999 Apr; 162(8):4472-81. PubMed ID: 10201984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythropoietin induces activation of Stat5 through association with specific tyrosines on the receptor that are not required for a mitogenic response.
    Quelle FW; Wang D; Nosaka T; Thierfelder WE; Stravopodis D; Weinstein Y; Ihle JN
    Mol Cell Biol; 1996 Apr; 16(4):1622-31. PubMed ID: 8657137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct mechanisms of STAT phosphorylation via the interferon-alpha/beta receptor. Selective inhibition of STAT3 and STAT5 by piceatannol.
    Su L; David M
    J Biol Chem; 2000 Apr; 275(17):12661-6. PubMed ID: 10777558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythropoietin induces tyrosine phosphorylation of the interleukin-3 receptor beta subunit (betaIL3) and recruitment of Stat5 to possible Stat5-docking sites in betaIL3.
    Chin H; Wakao H; Miyajima A; Kamiyama R; Miyasaka N; Miura O
    Blood; 1997 Jun; 89(12):4327-36. PubMed ID: 9192755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stress-induced phosphorylation of STAT1 at Ser727 requires p38 mitogen-activated protein kinase whereas IFN-gamma uses a different signaling pathway.
    Kovarik P; Stoiber D; Eyers PA; Menghini R; Neininger A; Gaestel M; Cohen P; Decker T
    Proc Natl Acad Sci U S A; 1999 Nov; 96(24):13956-61. PubMed ID: 10570180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lyn physically associates with the erythropoietin receptor and may play a role in activation of the Stat5 pathway.
    Chin H; Arai A; Wakao H; Kamiyama R; Miyasaka N; Miura O
    Blood; 1998 May; 91(10):3734-45. PubMed ID: 9573010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythropoietin hypersensitivity in primary familial and congenital polycythemia: role of tyrosines Y285 and Y344 in erythropoietin receptor cytoplasmic domain.
    Arcasoy MO; Karayal AF
    Biochim Biophys Acta; 2005 Apr; 1740(1):17-28. PubMed ID: 15878737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone-induced tyrosyl phosphorylation and deoxyribonucleic acid binding activity of Stat5A and Stat5B.
    Smit LS; Vanderkuur JA; Stimage A; Han Y; Luo G; Yu-Lee LY; Schwartz J; Carter-Su C
    Endocrinology; 1997 Aug; 138(8):3426-34. PubMed ID: 9231797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of the growth hormone (GH) receptor and JAK1 and JAK2 kinases in the activation of Stats 1, 3, and 5 by GH.
    Smit LS; Meyer DJ; Billestrup N; Norstedt G; Schwartz J; Carter-Su C
    Mol Endocrinol; 1996 May; 10(5):519-33. PubMed ID: 8732683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth hormone receptor cytoplasmic domain differentially promotes tyrosine phosphorylation of signal transducers and activators of transcription 5b and 3 by activated JAK2 kinase.
    Yi W; Kim SO; Jiang J; Park SH; Kraft AS; Waxman DJ; Frank SJ
    Mol Endocrinol; 1996 Nov; 10(11):1425-43. PubMed ID: 8923468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.